A considerable amount of research has focused on the relationship between polymorphisms in TAP1 and tumorigenesis development (17–19).On the one hand, in some cancers, such as colorectal cancers, researchers work to promote antigen presentation and thereby enhance tumor sensitivity to drugs (20–22). The gene discussed is TAP1; the disease is neoplasm.